SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Castillón JC
  • Gordoa TA
  • Bayonas AC
  • Carretero AC
  • García-Carbonero R
  • Pulido EG
  • Fonseca PJ
  • Lete AL
  • Plazas JG

Grupos

Abstract

Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, along with steadfast improvements in therapy, has led to better prognosis over time for advanced gastrointestinal and pancreatic neuroendocrine tumors. The aim of this guideline is to update evidence-based recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification, and therapeutic options, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, are reviewed and discussed, and treatment algorithms to guide therapeutic decisions are provided.

© 2023. The Author(s).

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

Clinical & Translational Oncology  SPRINGER INT PUBL AG

Tipo:
Article
Páginas:
2692-2706
PubMed:
37204633
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,764 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 12

Citas Recibidas en Scopus: 7

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Diagnosis; Guidelines; Neuroendocrine; Therapy

Campos de Estudio

Cita

Compartir